ATE199740T1 - Aus alternden zellen abgeleitete hemmer der dns- synthese - Google Patents

Aus alternden zellen abgeleitete hemmer der dns- synthese

Info

Publication number
ATE199740T1
ATE199740T1 AT93901236T AT93901236T ATE199740T1 AT E199740 T1 ATE199740 T1 AT E199740T1 AT 93901236 T AT93901236 T AT 93901236T AT 93901236 T AT93901236 T AT 93901236T AT E199740 T1 ATE199740 T1 AT E199740T1
Authority
AT
Austria
Prior art keywords
dna synthesis
synthesis inhibitors
aging cells
inhibitors derived
aging
Prior art date
Application number
AT93901236T
Other languages
English (en)
Inventor
James R Smith
Asao Noda Phd
Original Assignee
Baylor College Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baylor College Medicine filed Critical Baylor College Medicine
Application granted granted Critical
Publication of ATE199740T1 publication Critical patent/ATE199740T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/23—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a GST-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/61—Fusion polypeptide containing an enzyme fusion for detection (lacZ, luciferase)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/11—Antisense
    • C12N2310/111—Antisense spanning the whole gene, or a large part of it
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/32—Chemical structure of the sugar
    • C12N2310/322—2'-R Modification

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Nanotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dispersion Chemistry (AREA)
  • Toxicology (AREA)
  • Medical Informatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT93901236T 1991-12-16 1992-12-15 Aus alternden zellen abgeleitete hemmer der dns- synthese ATE199740T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US80852391A 1991-12-16 1991-12-16
US07/970,462 US5302706A (en) 1991-12-16 1992-11-02 Senescent cell derived inhibitors of DNA synthesis
PCT/US1992/010904 WO1993012251A1 (en) 1991-12-16 1992-12-15 Senescent cell derived inhibitors of dna synthesis

Publications (1)

Publication Number Publication Date
ATE199740T1 true ATE199740T1 (de) 2001-03-15

Family

ID=27123138

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93901236T ATE199740T1 (de) 1991-12-16 1992-12-15 Aus alternden zellen abgeleitete hemmer der dns- synthese

Country Status (12)

Country Link
US (3) US5302706A (de)
EP (1) EP0640143B1 (de)
JP (1) JP3865766B2 (de)
AT (1) ATE199740T1 (de)
AU (1) AU673992B2 (de)
CA (1) CA2125974C (de)
DE (1) DE69231739T2 (de)
DK (1) DK0640143T3 (de)
ES (1) ES2157215T3 (de)
GR (1) GR3035905T3 (de)
PT (1) PT640143E (de)
WO (1) WO1993012251A1 (de)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5302706A (en) * 1991-12-16 1994-04-12 Baylor College Of Medicine Senescent cell derived inhibitors of DNA synthesis
US6372249B1 (en) * 1991-12-16 2002-04-16 Baylor College Of Medicine Senscent cell-derived inhibitors of DNA synthesis
US5744300A (en) * 1993-03-24 1998-04-28 Geron Corporation Methods and reagents for the identification and regulation of senescence-related genes
ATE478144T1 (de) * 1993-08-30 2010-09-15 Baylor College Medicine Inhibitoren der dna synthese aus alternden zellen
CA2170641C (en) * 1993-08-30 2011-11-15 James R. Smith Senescent cell-derived inhibitors of dna synthesis
US6051376A (en) * 1994-09-30 2000-04-18 The Trustees Of Columbia University In The City Of New York Uses of mda-6
DK1650303T3 (da) 1993-10-27 2008-09-08 Univ Columbia Fremgangsmåde til generering af et subtraheret cDNA-bibliotek og anvendelse af det genererede bibliotek
WO1995013375A1 (en) * 1993-11-10 1995-05-18 The Johns Hopkins University Tumor suppressor waf1
US5491069A (en) * 1994-02-18 1996-02-13 The Regents Of The University Of California Biomarkers of cell senescence
US5856121A (en) * 1994-02-24 1999-01-05 Case Western Reserve University Growth arrest homebox gene
WO1995031183A1 (en) * 1994-05-16 1995-11-23 Washington University Cell membrane fusion composition and method
AU2644495A (en) * 1994-05-24 1995-12-18 Baylor College Of Medicine Mimetics of senescent cell derived inhibitors of dna synthesis
US5631156A (en) * 1994-06-21 1997-05-20 The University Of Michigan DNA encoding and 18 KD CDK6 inhibiting protein
AU729545B2 (en) * 1994-10-24 2001-02-01 Baylor College Of Medicine Senescent cell-derived inhibitors of DNA synthesis
GB9422175D0 (en) 1994-11-03 1994-12-21 Univ Dundee Indentification of the p21 waf1-pcna interaction site and therapeutic applications thereof
AU4502096A (en) * 1994-11-11 1996-06-06 Arch Development Corporation A process of inhibiting non-neoplastic pathological cell proliferation
US5700927A (en) * 1994-12-23 1997-12-23 The Children's Medical Center Corporation Tbc1 gene and uses thereof
AU5103996A (en) 1995-03-09 1996-10-02 Bavarian Nordic Research Institute A/S Vectors carrying therapeutic genes encoding antimicrobial peptides for gene therapy
US6149945A (en) * 1995-03-20 2000-11-21 Alberta Cancer Board Human fibroblast diffusable factors
US6025480A (en) * 1995-04-03 2000-02-15 Sloan-Kettering Institute For Cancer Research Isolated nucleic acid molecules encoding P57KIP2
US6322548B1 (en) 1995-05-10 2001-11-27 Eclipse Surgical Technologies Delivery catheter system for heart chamber
GB9509557D0 (en) 1995-05-11 1995-07-05 Univ Dundee PCNA binding substance
US5840059A (en) * 1995-06-07 1998-11-24 Cardiogenesis Corporation Therapeutic and diagnostic agent delivery
US6224584B1 (en) 1997-01-14 2001-05-01 Eclipse Surgical Technologies, Inc. Therapeutic and diagnostic agent delivery
EP0850066A1 (de) * 1995-07-20 1998-07-01 Worcester Foundation For Biomedical Research, Inc. Verfahren zur selektiven abtötung oder hemmung des wachstums von zellen, welche das waf1-gen exprimieren
US6143211A (en) * 1995-07-21 2000-11-07 Brown University Foundation Process for preparing microparticles through phase inversion phenomena
US5705350A (en) * 1995-08-29 1998-01-06 Duke University Transcription factor complexes in senescent cells
US7087582B1 (en) 1995-09-26 2006-08-08 Regents Of The University Of Michigan Combination for site-specifically transforming cells in vivo comprising a double-balloon catheter and nucleic acid comprising a gene encoding P21
ATE217023T1 (de) * 1995-10-13 2002-05-15 Austrian Nordic Biotherapeutic Retrovirale vektoren die inhibitoren der dna synthese (sdi-1) oder antisense sdi-1 nukleotid sequenzen tragen
US7074398B1 (en) 1995-10-13 2006-07-11 Gsf-Forschungszentrum Fuer Umwelt Und Gesundheit Gmbh Retroviral vectors carrying senescent cell derived inhibitors 1 (SDI-1)or antisense SDI-1 nucleotide sequences
GB9600518D0 (en) * 1996-01-11 1996-03-13 Ludwig Inst Cancer Res Regulator of cell proliferation
WO1997026327A1 (en) * 1996-01-18 1997-07-24 Fred Hutchinson Cancer Research Center Compositions and methods for mediating cell cycle progression
US5958769A (en) * 1996-01-18 1999-09-28 Fred Hutchinson Cancer Research Center Compositions and methods for mediating cell cycle progression
US20030027777A1 (en) * 1996-04-10 2003-02-06 Andrew Koff Methods for enhancing animal growth and cell proliferation by elimination of the cyclin-dependent kinase inhibitor function of p27Kip1
ATE333465T1 (de) * 1996-05-08 2006-08-15 Cyclacel Ltd Methoden und mittel zur hemmung der cdk4- aktivität
EP0941124A4 (de) * 1996-11-21 2004-12-15 Univ Nebraska Antisense-oligonukleotid zusammenstellungen zur gezielten tötung von krebszellen
KR20000062345A (ko) * 1996-12-26 2000-10-25 히라타 다다시 신규 폴리펩타이드, 신규 ｄｎａ 및 신규 항체
US6218109B1 (en) 1997-09-05 2001-04-17 Baylor College Of Medicine Mammalian checkpoint genes and proteins
US20030165888A1 (en) * 2001-07-18 2003-09-04 Brown Bob D. Oligonucleotide probes and primers comprising universal bases for diagnostic purposes
US6518017B1 (en) * 1997-10-02 2003-02-11 Oasis Biosciences Incorporated Combinatorial antisense library
WO1999021845A2 (en) * 1997-10-27 1999-05-06 Agouron Pharmaceuticals, Inc. 4-aminothiazole derivatives, their preparation and their use as inhibitors of cyclin-dependent kinases
US6489305B1 (en) * 1998-05-08 2002-12-03 Canji, Inc. Methods and compositions for the treatment of ocular diseases
US7691370B2 (en) * 1998-10-15 2010-04-06 Canji, Inc. Selectivity replicating viral vector
EP1173614A4 (de) * 1999-04-08 2003-10-29 Oasis Biosciences Inc Antisense oligonukleotide enthaltend universelle und/oder degenerierte basen
US6706491B1 (en) * 1999-04-09 2004-03-16 The Board Of Trustees Of The University Of Illinois Reagents and methods for identifying and modulating expression of genes regulated by p21
US20020156247A1 (en) * 2000-01-12 2002-10-24 Elledge Stephen J. Mammalian checkpoint genes and proteins
NZ546983A (en) * 2003-11-24 2009-05-31 Canji Inc Reduction of dermal scarring
JP5117189B2 (ja) * 2004-08-27 2013-01-09 サイクラセル リミテッド プリン及びピリミジンｃｄｋ阻害剤、並びに自己免疫疾患の治療のためのそれらの使用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI890312A (fi) * 1988-01-25 1989-07-26 Oncogen Amfiregulin: ett nytt bifunktionellt tillvaext modulerande glykoprotein.
CA2070393A1 (en) * 1989-10-18 1991-04-19 Charles M. Cohen Biosynthetic constructs of tgf-beta
WO1991015229A1 (en) * 1990-04-04 1991-10-17 The American National Red Cross Modified heparin binding growth factors
IE20010427A1 (en) * 1990-04-10 2003-03-05 Canji Inc Gene therapy for cell proliferative diseases
US5302706A (en) * 1991-12-16 1994-04-12 Baylor College Of Medicine Senescent cell derived inhibitors of DNA synthesis

Also Published As

Publication number Publication date
PT640143E (pt) 2001-09-27
EP0640143B1 (de) 2001-03-14
JPH07502651A (ja) 1995-03-23
CA2125974A1 (en) 1993-06-24
CA2125974C (en) 1999-06-29
WO1993012251A1 (en) 1993-06-24
EP0640143A4 (de) 1996-10-23
EP0640143A1 (de) 1995-03-01
ES2157215T3 (es) 2001-08-16
AU673992B2 (en) 1996-12-05
US5840845A (en) 1998-11-24
GR3035905T3 (en) 2001-08-31
DE69231739T2 (de) 2001-09-13
US5302706A (en) 1994-04-12
AU3324393A (en) 1993-07-19
JP3865766B2 (ja) 2007-01-10
DE69231739D1 (de) 2001-04-19
US5424400A (en) 1995-06-13
DK0640143T3 (da) 2001-07-16

Similar Documents

Publication Publication Date Title
DE69231739D1 (de) Aus alternden zellen abgeleitete hemmer der dns-synthese
DE69433647D1 (de) Menschliche proteaseinhibitoren vom kunitztyp
ATE196428T1 (de) Verwendung von gentisinsäure oder gentisylalkohol zur stabilisierung von radio-markierten peptiden und proteinen
IT1058202B (it) Composizioni di cianoacrilato utili in particolare come adesivi
DK0762897T3 (da) Fremgangsmåde til forebyggelse af aggregering af proteiner/peptider ved rehydratisering eller optøning
TR199902545T2 (xx) Kalp damar hastal�klar�n�n �nlenmesinde siklooksijenaz-2 inhibit�rlerini kullanma y�ntemi
DE69226558D1 (de) Verfahren zur Korrosionverminderung von an Hochtemperaturwasser ausgesetzten Komponenten
ATE318841T1 (de) Biarylalkansäuren in der verwendung als zelladhäsionsinhibitoren
DE69609193D1 (de) Neosäure als korrosinsinhibitoren
DK332684D0 (da) Modificerede protease-inhibitorer samt deres fremstilling og anvendelse
UA35574C2 (uk) Похідні заміщеної гетероциклом фенілциклогексанкарбонової кислоти, суміші їх ізомерів або окремі ізомери та їх солі
NL7713091A (nl) Derivaten van de trypsine-callicreine-remmer uit runderorganen (bpti) met proteasen remmende werking en antiflogistische werking, alsmede de bereiding van dergelijke derivaten en preparaten, die deze derivaten bevatten.
FR2338334A1 (fr) Esters partiels d'acides hydroxy-polycarboxyliques et leur utilisation comme inhibiteur de corrosion et d'entartrage des reseaux d'eau circulante
AU7303301A (en) Isolated nucleic acid molecules which encode t cell inducible factors, or interleukin-21, the proteins encoded, and uses thereof
IT1271310B (it) Procedimento per l'ottenimento di correnti distinte di metanolo ed etanolo,di n-propanolo,di isobutanolo,impiegabili nella sintesi di prodotti alto ottanici,da miscele contenti detti alcoli con acqua ed altri composti bassobollenti e altobollenti
EP0723402A4 (de) Inhibitoren der dna synthese aus alternden zellen
IT1051482B (it) Emulsione acquosa stabile di i..i 2..tricloro..1..2..2..trifluoretano .. particolarmente utile come detergente
AR009818A1 (es) Proteasas y sus variantes que tienen inhibidores de proteasa peptida fundidos en ellas
IT1056979B (it) Lega per oggetti molto resistenti lla corrosione e o capaci di sopportare grandi sollecitazione meccaniche
DE69331018D1 (de) Neutrophilen inhibitoren aus nematoden
CH529560A (de) Verwendung von biologischen Proteasen-Inhibitoren als Desodorantien
ATE443148T1 (de) Transkriptionale regulator-nukleinsäuren, polypeptide und verfahren ihrer anwendung
DE60108729D1 (de) Phosphoglycerat-kinase-1-promotor aus rhizopus oryzae und dessen verwendung
SE9303304D0 (sv) Ett energi fördelande system
Williams A Century of Fundamental Constants Work at NBS-NIST

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee